However, there are exceptions, suggesting that LILRB4 may also play a tumor-suppressive role in tumor development, such as in chronic lymphocytic leukemia (CLL), where LILRB4 is ectopically expressed and a selective marker for CLL malignancy. The gene discussed is LILRB4; the disease is neoplasm.